Chinese Market for Cardiovascular Devices Forecast to Grow 18% Annually Through 2013, Driven by Expanded Services and Procedures.HUNTINGTON BEACH, Calif. -- According to a new report, 2009 Opportunities in Chinese Cardiovascular Device Markets, distributed exclusively by Life Science Intelligence (LSI LSI: see integrated circuit. (Large Scale Integration) Between 3,000 and 100,000 transistors on a chip. See SSI, MSI, VLSI and ULSI. ) and published by Health Research International (HRI HRI Horse Racing Ireland HRI High Resolution Instrument HRI Human-Robot Interaction HRI Hellenic Resources Institute (Greece) HRI Human Rights Internet (Ottawa, Canada) ), the Chinese market for cardiovascular devices will reach $1.37 billion in 2013. The combination of a large, aging population and strong economic growth has focused significant attention on China as the health care market of the future. Other reports and analyses predict substantial growth for China's medical device markets; however, rarely do they provide hard data regarding epidemiological and procedure trends driving demand, the domestic health delivery system, domestic manufacturing capabilities, and cultural issues impacting medical device utilization. This report fills this gap with a detailed analysis of cardiovascular epidemiology in China; procedure trends; profiles of leading cardiovascular hospitals, physicians, and domestic suppliers; and cultural factors impacting health care in China. In addition, the 244-page report addresses the current and future status of interventional cardiology interventional cardiology Cardiology The subspecialty of cardiology dedicated to the diagnosis, medical and mechanical therapy, pre- and post-procedure management of adult patients with acute and chronic forms of cardiovascular disease amenable to catheter-based , cardiac surgery, and rhythm management in China. Nearly 100 exhibits address major procedures and product markets, including: PCI (1) (Payment Card Industry) See PCI DSS. (2) (Peripheral Component Interconnect) The most widely used I/O bus (peripheral bus). disposables, coronary stents, percutaneous defect repair technologies, cardiopulmonary bypass cardiopulmonary bypass n. A procedure to circulate and oxygenate the blood during heart surgery involving the diversion of blood from the heart and lungs through a heart-lung machine and the return of oxygenated blood to the aorta. disposables, prosthetic pros·thet·ic adj. 1. Serving as or relating to a prosthesis. 2. Of or relating to prosthetics. prosthetic serving as a substitute; pertaining to prostheses or to prosthetics. heart valve products, endovascular aneurysm aneurysm (ăn`y  rĭzəm), localized dilatation of a blood vessel, particularly an artery, or the heart. repair products, advanced
electrophysiology systems and catheters, radiofrequency ablation Radiofrequency ablation (RFA)A technique for removing a tumor by heating it with a radiofrequency current passed through a needle electrode. Mentioned in: Liver Cancer, Prenatal Surgery systems and disposables, pacemakers, and implantable cardioverter defibrillators. These exhibits and the market analyses include the results of a major survey of five leading Chinese hospitals regarding their cardiovascular procedures and products. Immediate access to the Table of Contents for this report is available at: lsintelligence.com/market-reports-page.php?id=HRI-0511. 2009 Opportunities in Chinese Cardiovascular Device Markets concludes that two factors will continue to drive developments in China's health care markets through 2013: continued, strict government control of the health delivery system, and continued observation of the Chinese virtue of "patience." Now is the window of opportunity to enter China and participate in both its health care growth and product markets. Even with the constraints identified in this report, cardiovascular product sales are projected to increase 18% annually through 2013, attesting to the significant opportunity in China. About Health Research International (HRI) Founded in 1978, HRI (www.healthri.com) provides the pharmaceutical and medical device industries with reliable, comprehensive, and meticulously researched market analysis that incorporates strategic vision and a thorough understanding of competing medical technologies. Quality, experience, and follow through have been the cornerstones of their custom consulting, online surveys, pricing sensitivity studies, FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. work, and market reports. About Life Science Intelligence (LSI)[R] LSI delivers high-quality market data and information to medical technology executives, entrepreneurs, and investors. LSI produces the EMT See Efficient markets theory. (Emerging Medical Technologies)[R] Database, medtech market reports, and provides global custom research services, including market assessments and physician surveys. In addition, LSI partners with top-tier information companies such as Health Research International (HRI) and Windhover/Medtech Insight to distribute their high-end information products. www.LSintelligence.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion